| __timestamp | BioCryst Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 4060800000 |
| Thursday, January 1, 2015 | 48257000 | 4603900000 |
| Friday, January 1, 2016 | 26353000 | 5280600000 |
| Sunday, January 1, 2017 | 25186000 | 4946200000 |
| Monday, January 1, 2018 | 20653000 | 4731700000 |
| Tuesday, January 1, 2019 | 48835000 | 4837400000 |
| Wednesday, January 1, 2020 | 17812000 | 5063300000 |
| Friday, January 1, 2021 | 157170000 | 4138700000 |
| Saturday, January 1, 2022 | 270827000 | 4451600000 |
| Sunday, January 1, 2023 | 331412000 | 4655600000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, revenue generation is a key indicator of a company's market strength. Over the past decade, Perrigo Company plc has consistently outperformed BioCryst Pharmaceuticals, Inc. in terms of revenue. From 2014 to 2023, Perrigo's annual revenue averaged around $4.7 billion, dwarfing BioCryst's average of approximately $96 million. This stark contrast highlights Perrigo's dominant market position, with revenues peaking at $5.3 billion in 2016. Meanwhile, BioCryst has shown a promising upward trend, with a remarkable 1,900% increase in revenue from 2014 to 2023, reaching $331 million. This growth trajectory suggests BioCryst's potential to capture a larger market share in the future. As the pharmaceutical industry evolves, these revenue trends provide valuable insights into the strategic positioning and growth potential of these two companies.
Merck & Co., Inc. and Perrigo Company plc: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited and Perrigo Company plc: A Comprehensive Revenue Analysis
Viatris Inc. vs Perrigo Company plc: Examining Key Revenue Metrics
Annual Revenue Comparison: Exelixis, Inc. vs Perrigo Company plc
Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: Cytokinetics, Incorporated or BioCryst Pharmaceuticals, Inc.?
Alkermes plc vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Perrigo Company plc vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Revenue Showdown: Perrigo Company plc vs ImmunityBio, Inc.
Perrigo Company plc vs Galapagos NV: Examining Key Revenue Metrics
Cost of Revenue Comparison: Perrigo Company plc vs BioCryst Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.